留学社区

目录

雅思阅读真题模拟:Why did a promising heart drug fail?

字典 |

2011-06-01 11:39

|

【 liuxue86.com - 雅思阅读 】

  本文来源于北京语言大学雅思培训中心向网友提供的在难度、长度、题材、题型方面与雅思考试近似的练习。这些练习,均以最新的国外报刊上的文章为素材,按雅思阅读的题型,出题并提供答案及简单注释。欢迎大家积极使用。 

  Why did a promising heart drug fail? 

  Doomed drug highlights complications of meddling with cholesterol. 

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs). In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. "There have been no red flags to my knowledge," says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. "This cancellation came as a complete shock." 

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the 'bad' low-density lipoproteins. 

  Under pressure 

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. "You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap. 

  Going up 

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. "The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL," says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore. 

  (613 words nature) 

  想了解更多雅思阅读网的资讯,请访问: 雅思阅读

本文来源:https://ielts.liuxue86.com/i/235572.html
延伸阅读
对于想提升雅思阅读成绩的同学来说,大家可以看看出国留学网准备的怎样提升雅思阅读考试的基本能力?下面就来看看吧!巧用文章记单词根据自己的英语基础制定出每天能够坚持的,切实可行的背单词
2019-05-17
雅思考试阅读部分的题型,主要可以八种题型。这八种题型难度和出现频率都不尽相同,在以后会对部分题型进行更为详细的介绍。今天就整体地介绍一下2019年雅思阅读开始备考指南。在做雅思阅读
2019-05-11
雅思阅读做题慢游哪些原因?这是正在备考雅思阅读的同学需要了解的,那么接下来就和出国留学网一起来看看怎样提高雅思阅读的速度?(1)边看雅思阅读文章边默读出来以前初高中学英语的时候,老
2019-05-08
对于雅思考试来说,时间是比较关键的,那么今天就和出国留学网的小编一起来了解一下如何节省雅思阅读时间?第1步雅思阅读考试中,考生拿到雅思阅读的试卷后应该首先应该闭上眼睛,稳定一下自己
2019-04-26
对于很多准备考雅思的同学们来说,不知道准备得怎么样?那么今天就和出国留学网的小编一起来了解一下雅思阅读考试解题技巧。listofheading题①根据topicsentence解题
2019-03-16
对于很多准备考雅思的同学来说,雅思阅读是比较难的,那么今天就和出国留学网的小编一起来了解一下这篇雅思阅读真题精选。NatureorNurture?AAfewyearsago,ino
2018-04-08
雅思阅读的备考,比较好的方法就是多找一些月的真题来做,接下来就和出国留学网来看看雅思阅读模拟练习题:示意图题。What'ssofunny?JohnMcCronereviewsrec
2018-07-09
想要提升雅思阅读的成绩,那么想要同学们平时有没有做一些习题来提升自己的雅思阅读做题能力呢?今天就和出国留学网来看看雅思阅读模拟练习题:段落标题题。雅思阅读模拟练习题:段落标题题Pe
2018-07-09
对于准备考雅思的同学来说,不知道雅思写作作文准备得怎么样呢?今天就和出国留学网的小编一起来了解一下雅思阅读真题以及解析:南极气候。雅思阅读机经真题解析-南极气候Antarctica
2018-04-18
对于准备考雅思的同学来说,不知道雅思写作作文准备得怎么样呢?今天就和出国留学网的小编一起来了解一下雅思阅读真题暗示词有哪些?一、解题暗示词是什么?即在做题过程中,如果按照平常划定位
2018-03-29